Editas Medicine Announces Second Quarter 2017 Results and Update
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/3/2026
- Wall Street rallies as Fed's Waller eases rate hike fears
- Fed’s Waller open to September rate hold - if disinflation holds up
- Broadcom raises AI chip forecast as Big Tech keeps writing bigger checks
- Nvidia to acquire AI platform Hugging Face in landmark $12.9B deal
- Tesla to unveil Cybercab Texas today, details are few
Editas Medicine (EDIT) Tops Q2 EPS by 6c
August 9, 2017 4:04 PM EDTEditas Medicine (NASDAQ: EDIT) reported Q2 EPS of ($0.65), $0.06 better than the analyst estimate of ($0.71). Revenue for the quarter came in at $3.1 million versus the consensus estimate of $2.4 million.
For earnings history and earnings-related data on Editas Medicine (EDIT) click here.
... More